Jimtash, the following is from Radient's own website.
"Our Onko-Sure™ in vitro diagnostic test enables physicians and their patients to effectively monitor and/or detect solid tumor cancers by measuring the accumulation of specific breakdown products in the blood called Fibrin and Fibrinogen Degradation Products (FDP)."
The following is from Medicine Plus website for the possible reasons why FDP's could be high. cancer is not even mentioned.
"Increased FDPs may be a sign of primary or secondary fibrinolysis (clot-dissolving activity) due to a variety of causes, including:
•Abruptio placentae
•Burns
•Congenital heart disease
•Disseminated intravascular coagulation (DIC)
•Hypoxia
•Infections
•Intrauterine fetal death
•Leukemia
•Liver disease (See: cirrhosis)
•Portacaval shunt
•Preeclampsia
•Recent blood transfusion
•Recent surgery that involved a heart and lung bypass pump
•Renal disease (See: kidney failure)
•Septicemia
•Thromboembolic states
•Transplant rejection
•Transfusion reaction"
As a test for cancer, Onko Sure has very little useful value. It is all just HYPE from Radient.
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.
